Dr. Alan Venook is the Madden Family Distinguished Professor of Medical Oncology and Translational Research at UCSF and is the Shorenstein Associate Director for Program Development at the Helen Diller Family Comprehensive Cancer Center at UCSF. He was the founding Chairman of the NCI’s Hepatobiliary Task Force, chaired the GI Committee of the Alliance for Clinical Trials in Oncology from 2010 -2016 and was an Associate Editor of the Journal of Clinical Oncology from 2010 - 2015.
Dr. Venook’s research interests include the regional treatment of tumors in the liver and the development of new therapies for colorectal and liver cancers. It was his observation from data in the advanced colorectal cancer study -- CALGB/SWOG 80405 – that helped define “sidedness”, the phenomenon that colon cancers arising in the right colon are biologically different than those that arise on the left side. Recently his group has turned its focus to understanding the interactions between immunotherapy and the microbiome and the marked increase in colorectal cancer in young adults.
August 5, 1999 - May 31, 2023 - Cancer Center Support Grant , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P30CA082103
December 1, 1974 - March 31, 2009 - General Clinical Research Center , Co-Investigator . Sponsor: NIH, Sponsor Award ID: M01RR000079
July 28, 1993 - March 31, 2003 - CANCER AND LEUKEMIA GROUP B , Principal Investigator . Sponsor: NIH, Sponsor Award ID: U10CA060138
Rutgers College, New Brunswick, New Jersey, BA, 1976, Biological Sciences
University of California San Francisco, MD, 1980, Medicine
University of California San Francisco, Internship, 1981, Internal Medicine
University of California, Davis, Residency, 1985, Internal Medicine
University of California San Francisco, Fellowship, 1987, Hematology/Oncology